Search

everythinglearnresearchcommunity

for

Search:↓

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Most injecting drug users in the study had hepatitis C and skin problems, which moderately affected their quality of life.

Scalp skin condition LEDS has similar features to Zoon's balanitis, a mucosal skin disorder.

Henna ointment may help reduce itching and improve wound healing in patients with epidermolysis bullosa.

Trichoscopy helped diagnose a teenage girl's hair loss as monilethrix.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Both treatments help hair regrowth, with PRP being slightly better.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

A spermidine-based supplement may help hair grow longer by keeping it in the growth phase.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

Yellow dots are common in severe alopecia areata.

Feily's method prevents scalp necrosis in dense hair transplants by allowing time for blood flow to return before grafting.

A man developed a rare skin condition after a hair transplant surgery.

DPCP can help regrow hair in some people with severe alopecia.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

DPCP is effective for treating severe alopecia areata, but relapse is common.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Diphencyprone helped most patients with alopecia areata regrow some hair.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.